title: Interleukin-I antagonists.
authors.affiliation: Immunex Research and Development Corporation, Seattle, WA 98101, USA.
authors.forename: S K
authors.initials: SK
authors.lastname: Dower
authors.forename: W
authors.initials: W
authors.lastname: Fanslow
authors.forename: C
authors.initials: C
authors.lastname: Jacobs
authors.forename: S
authors.initials: S
authors.lastname: Waugh
authors.forename: J E
authors.initials: JE
authors.lastname: Sims
authors.forename: M B
authors.initials: MB
authors.lastname: Widmer
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000628:therapy; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D011485:Protein Binding; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000502:physiology*; D011994:Recombinant Proteins; D012795:Sialoglycoproteins; D012882:Skin Tests; D012995:Solubility
chemical_list: C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D012795:Sialoglycoproteins